Indigo Diabetes appoints Paul Moraviec as Chairman of the board

Harrold van Barlingen has been involved as chairman and boardmember of portfolio company Indigo Diabetes from the very beginning. Now it is time to pass the baton.

We’re delighted to welcome Paul Moraviec, former CEO of ConvaTech with decades of leadership experience in the global #MedTech sector, has been appointed Chairman of the Board of Indigo Diabetes. His experience will be invaluable as Indigo continue to develop our subcutaneous continuous multi metabolite monitoring (CMM) device.

Harrold van Barlingen will continue to retain his position as board member.

Indigo Chairman - Paul.jpg